Procter & Gamble, US7427181091

Procter & Gamble Stock (US7427181091): Insider RSU grant as shares ease in Dow Jones trade

12.06.2026 - 09:50:26 | ad-hoc-news.de

Procter & Gamble shares in the Dow Jones ticked slightly lower on Thursday while a new Form 4 filing disclosed a director’s restricted stock unit grant under the company’s 2025 Stock and Incentive Compensation Plan.

Procter & Gamble, US7427181091
Procter & Gamble, US7427181091

Responsible: ad hoc news Stocks & Analysis Desk. Reviewed prior to publication on June 11, 2026 at 6:56 PM ET. Details in the imprint.

Procter & Gamble stock was slightly weaker in Thursday afternoon New York trading, even as a fresh insider filing showed a small equity award for one of the company’s directors under its long term incentive plan. According to finanzen.net, the Dow Jones component recently traded at about $148.82, down 0.2 percent on the day, after touching an intraday low near $148.71. A separate Form 4 submitted to the U.S. Securities and Exchange Commission detailed the grant of 253 restricted stock units to director Christine M. McCarthy on June 9, 2026, recorded at a stated price of $0.00 per share as equity compensation.

Insider Form 4: Director receives 253-share RSU grant

The latest insider activity at Procter & Gamble centers on a compensation related award rather than an open market trade. In a Form 4 filing summarized by StockTitan, the company reported that board member Christine M. McCarthy was granted 253 shares of common stock in the form of restricted stock units on June 9, 2026. The transaction was coded as type "A" for a grant, award or other acquisition, and carried a stated price of $0.00 per share because it was awarded under Procter & Gamble’s 2025 Stock and Incentive Compensation Plan rather than purchased on the market.

The filing notes that these restricted stock units include dividend equivalents, meaning that additional units are credited over time in lieu of cash dividends on the underlying shares. Following this grant and the associated dividend equivalents, McCarthy’s direct holdings in Procter & Gamble common stock increased to a reported total of 17,512.6591 shares. Because the award is an equity based form of compensation, it does not represent a director buying or selling stock based on a valuation view, but it does modestly increase insider ownership in the consumer products company.

The 2025 Stock and Incentive Compensation Plan is designed to align management and director pay more closely with shareholder interests by linking a portion of compensation to Procter & Gamble’s long term performance. Grants of restricted stock units typically vest over a multiyear period, creating a retention tool and tying the recipient’s personal wealth more directly to the company’s share price. While each grant is small relative to the company’s roughly $350 billion market capitalization, cumulative insider equity awards can gradually increase the proportion of stock directly or indirectly held by insiders.

For outside investors, the distinction between compensation related grants and discretionary market trades can be important when interpreting Form 4 activity. According to the StockTitan summary, the McCarthy transaction was not an open market buy or sell and therefore provides less direct insight into her assessment of Procter & Gamble’s current valuation. Instead, it signals the ongoing use of equity based compensation to reinforce long term alignment between the board and shareholders, a practice that is widespread among large U.S. blue chips, including Dow Jones peers in the consumer and household products space.

Recent filings also indicate that institutional investors continue to actively adjust their stakes in Procter & Gamble, underscoring the stock’s role as a core holding in many diversified portfolios. Janney Montgomery Scott LLC disclosed in an SEC filing that it sold 13,346 shares of Procter & Gamble during a recent period, trimming but not eliminating its position. MarketBeat’s summary of that filing notes that the firm still holds a substantial number of shares after the sale, reflecting a portfolio rebalancing rather than a full exit. Such moves are common among asset managers managing client mandates when valuations, risk targets or broader asset allocation strategies shift.

Alongside the insider and institutional ownership disclosures, Procter & Gamble has been guiding investors with medium term financial targets. According to MarketBeat, the company has set its fiscal 2026 earnings per share guidance in a range of $6.83 to $7.09 under U.S. GAAP. Separately, analyst compilations referenced by finanzen.net indicate that Wall Street currently expects earnings of about $6.89 per share for the 2026 financial year. These figures suggest that the company’s own outlook and the consensus estimates are broadly aligned, with analysts modeling modest profit growth in the mid single digit percentage range compared with recent years.

On the trading side, the stock’s modest decline on Thursday afternoon followed a slightly firmer close the previous day, highlighting the relatively tight range in which Procter & Gamble has been moving. Finanzen.ch reported that on Wednesday afternoon the shares traded near $149.22 in New York, up about 0.4 percent at that time, putting the stock marginally higher for that session. By Thursday’s New York afternoon trading, finanzen.net data showed the price easing back to roughly $148.82, leaving the stock down around 0.2 percent, with an intraday low about $148.71. These fluctuations of less than 1 percent reflect the typically defensive character of large consumer staples names, which tend to exhibit lower volatility than the broader market.

Procter & Gamble’s role as a Dow Jones Industrial Average component and a major member of the consumer staples cohort means it is often used by investors as a proxy for household and personal care spending in the U.S. and globally. The company’s core brands span laundry detergents, baby care products, grooming, and oral care, giving it exposure to demand that is less cyclical than discretionary retail categories. That backdrop partly explains why the stock can be influenced as much by changes in bond yields, dividend expectations, and defensive sector rotations as by short term company specific headlines. In recent sessions, P&G has traded in line with broader moves in defensive large caps rather than experiencing large idiosyncratic swings.

Beyond the capital markets updates, Procter & Gamble continues to highlight its brand and sustainability initiatives through corporate communications and survey based research. In a recent company news release, P&G and the American Academy of Family Physicians presented survey data showing that 76 percent of Americans say they care about their oral health, but only 3 percent associate oral health with whole body health. While this survey is not directly tied to current share price moves, it underscores the company’s emphasis on health related consumer education for brands in its oral care portfolio. Separately, industry coverage has noted that P&G’s long serving Chief Sustainability Officer, Virginie Helias, is stepping down after nearly four decades at the company, including 10 years leading sustainability. Leadership changes in this area can shape how investors evaluate the company’s long term environmental and social strategy, even when they do not move the stock in the short term.

For now, the key stock specific disclosure is the small RSU grant to director Christine M. McCarthy, which adds incrementally to insider holdings without signaling an active buy or sell decision. Combined with continued institutional portfolio adjustments and a fiscal 2026 earnings outlook centered around the mid to high $6 per share range, the latest data points keep the focus on Procter & Gamble’s role as a large cap, dividend paying consumer staples name within the Dow Jones. Investors watching the stock may continue to weigh the relative appeal of its defensive cash flow profile and dividend stream against broader market conditions, interest rate trends, and valuation levels in the consumer staples sector.

Procter & Gamble at a glance

  • Name: Procter & Gamble Co.
  • Industry: Consumer staples, household and personal care products
  • Headquarters: Cincinnati, Ohio, United States
  • Core markets: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
  • Revenue drivers: Branded household care, fabric and home care, baby and feminine care, grooming, oral care and personal health products
  • Listing: New York Stock Exchange, ticker PG, member of the Dow Jones Industrial Average and S&P 500
  • Trading currency: U.S. dollar (USD)

Follow Procter & Gamble developments

Stay on top of new filings, earnings updates and sector news that could influence the Procter & Gamble share price over time.

More Procter & Gamble news Investor Relations

What the community is saying about Procter & Gamble

YouTube X TikTok Instagram

This article was created with a.i. assistance and editorially reviewed. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.

en | US7427181091 | PROCTER & GAMBLE | boerse | 69525107 | bgmi